# EDGAR Filing Document

**Accession Number:** 0000794172
**File Stem:** 0001193125-23-035915
**Filing Date:** 2023-2
**Character Count:** 2892
**Document Hash:** 1e1cbae67dea442646e06ba1682bc156
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-035915.hdr.sgml**: 20230213

**ACCESSION NUMBER**: 0001193125-23-035915

**CONFORMED SUBMISSION TYPE**: 15-12G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230213

**DATE AS OF CHANGE**: 20230213

**EFFECTIVENESS DATE**: 20230213

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MERIDIAN BIOSCIENCE INC
- **CENTRAL INDEX KEY:** 0000794172
- **STANDARD INDUSTRIAL CLASSIFICATION:** IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
- **IRS NUMBER:** 310888197
- **STATE OF INCORPORATION:** OH
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 15-12G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-14902
- **FILM NUMBER:** 23619029

**BUSINESS ADDRESS:**
- **STREET 1:** 3471 RIVER HILLS DR
- **CITY:** CINCINNATI
- **STATE:** OH
- **ZIP:** 45244
- **BUSINESS PHONE:** 5132713700

**MAIL ADDRESS:**
- **STREET 1:** 3471 RIVER HILLS DRIVE
- **CITY:** CINCINNATI
- **STATE:** OH
- **ZIP:** 45244

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MERIDIAN DIAGNOSTICS INC
- **DATE OF NAME CHANGE:** 19920703

------

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

------

**FORM 15** 

------

**CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION** 

**UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934** 

**OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)** 

**OF THE SECURITIES EXCHANGE ACT OF 1934** 

**Commission File Number: 0-14902** 

------

## MERIDIAN BIOSCIENCE, INC.
**(Exact name of registrant as specified in its charter)** 

------

**3471 River Hills Dr** 

**Cincinnati, Ohio 45244** 

**(513) 271-3700** 

**(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)** 

**Common Stock, no par value** 

**(Title of each class of securities covered by this Form)** 

**None** 

**(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)** 

------

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

---

| | |
|:---|:---|
|  Rule 12g-4(a)(1) | ☒ |
|  Rule 12g-4(a)(2) | ☐ |
|  Rule 12h-3(b)(1)(i) | ☒ |
|  Rule 12h-3(b)(1)(ii) | ☐ |
|  Rule 15d-6 | ☐ |

---

Approximate number of holders of record as of the certification or notice date:

Common Stock, no par value per share: 1

------

Pursuant to the requirements of the Securities Exchange Act of 1934, Meridian Bioscience, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

---

| | | |
|:---|:---|:---|
| Date: February 13, 2023 | Meridian Bioscience, Inc. | Meridian Bioscience, Inc. |
|  | By: | /s/ Jack Kenny |
|  | Name: | Jack Kenny |
|  | Title: | Chief Executive Officer |

---